glp 1 drugs fda approved Comparing Ozempic, Wegovy and Other GLP-1 The U.S. Food and Drug
Description
Insurance and Accessibility Let's be real: insurance coverage for GLP-1s can be challenging
Broader use also increased the number of people potentially exposed to delayed gastric emptying, severe gastrointestinal symptoms, and other reported complications

Interested in learning more

The most recently marketed Tirzepatide targets not only the GLP-1 receptors, but also the Glucose-dependent Insulinotropic Polypeptide (GIP) receptors, which have similar important functions in blood glucose regulation

2024 Jun 18;15(1):5177

2016;310(9):E77481
